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1. Introduction 
Soybean [Glycine max (L.) Merrill] is one of the oldest cultivated crops of the Far East. For 
centuries, the Oriental people, including the Chinese, Japanese, Koreans, and Southeast 
Asians, have used soybean as a staple source of dietary protein and oil. It is one of the five 
commercial food crops, besides rice, wheat, barley, and millet. Soybean is very important for 
vegetarians and vegans because of its high protein content and abundance of vitamins, 
minerals, and fiber. Because of its versatility, it can be prepared into a variety of foods, 
including fermented and nonfermented foods. 
Asians consume about 20–80 g of traditional soy foods daily, the most common being tofu, 
miso, and tempeh (Fournier et al., 1998; Messina & Flickinger, 2002), whereas Americans 
consume only about 1–3 g daily (Cohen et al., 2000; Fournier et al., 1998), mostly in 
processed forms such as soy drinks, breakfast cereals, and energy bars. Soybean-based foods 
have generated much interest because of the evidence that consumption of large amounts of 
soybean can lower the risk of chronic diseases such as cardiovascular disease and cancer; 
this effect is particularly noticeable among Asian populations because of their high soy food 
intake (Kulling et al., 2001; Persky et al., 2002; Tikkanen & Adlercreutz, 2000). In addition, 
consumption of soy foods may reduce the risk of osteoporosis and help alleviate 
menopausal symptoms (Genovese & Lajolo, 2002; Messina, 2000; Persky et al., 2002), which 
are major health concerns for women. 
Soybean-based foods contain an array of biologically active compounds that can confer 
important health benefits such as antioxidant effects (Setchell, 1998; Tsai & Huang, 1999). 
These phytochemicals include saponins, phytates, protease inhibitors, phenolic acids, and 
lecithin, all known for their anticancer potential (Cohen et al., 2000; Messina & Flickinger, 
2002); phytosterols, which have hypocholesterolemic effects; isoflavones, which are known 
for several health benefits (Fukui et al., 2002); and omega-3 fatty acids, which have well-
recognized cardioprotective effects. Among these compounds, isoflavones have attracted 
the most attention (Messina & Flickinger, 2002; Messina & Loprinzi, 2001).  
The proteins β-conglycinin (7S globulin) and glycinin (11S globulin) constitute up to 90% of the 
total soy protein (Gianazza et al., 2003). Evaluation of these dietary proteins is very interesting 
because their hydrolysis by proteases produces peptides with biological activities. A growing 
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body of scientific evidence has revealed that many food proteins and peptides exhibit specific 
biological activities in addition to their established nutritional value. Bioactive peptides 
present in foods may help to reduce the worldwide epidemic of chronic diseases. Functional 
proteins and peptides are now an important category within the nutraceutical food sector. 
Many bioactive peptides have been isolated from soybean. Numerous studies of the 
enzymatic or chemical hydrolysis of soybean proteins have demonstrated their functional 
properties and physiological effects such as antimicrobial, antifungal, anticancer, anti-
obesity, antihypertensive, anti-inflammatory, hypocholesterolemic, immunostimulatory, 
and antioxidant activities. Further, many gene expression systems such as Escherichia coli 
and Pichia pastoris have been employed to produce recombinant proteins and peptides. In 
this chapter, we review the physiological properties of bioactive peptides derived from 
soybean proteins and discuss the production of soybean peptides by genetic engineering. 
2. The actions and beneficial properties of bioactive peptides from soybean 
Bioactive peptides are usually encrypted in the amino acid sequences of food proteins 
(Korhonen & Pihlanto, 2003). Such peptides are inactive within the sequences of precursor 
proteins, but limited hydrolysis (chemical or fermentation) may unravel the compact protein 
structures and thereby expose the amino acid residues and patches for inhibiting oxidation. 
As summarized in Figure 1, soybean-derived bioactive peptides have many beneficial 
properties, including hypolipidemic and hypocholesterolemic effects, hypotensive effects, 
improvement in arterial compliance and endothelial function, insulin resistance, and weight 
loss in obesity (Erdman, 1995; Friedman & Brandon, 2001; Hermansen et al., 2001; Merritt, 
2004; Sirtori et al., 1995). 
 
 
Fig. 1. Beneficial properties of bioactive peptides from soybean. 
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2.1 Hypocholesterolemic activity 
The US Food and Drug Administration has approved health claims concerning the role of 
soy protein in reducing the risk of coronary heart disease; only people with soy allergy 
(about 0.5% of the global population) should avoid eating foods containing soy protein. 
However, a recent randomized, double-blind, parallel-intervention trial showed no 
significant effect of soy supplementation (30 g soy protein, 9 g cotyledon fiber, 100 mg 
isoflavones) on blood lipid levels compared with a placebo (30 g casein) in 
hypercholesterolemic subjects after 24 weeks (Hermansen et al., 2005). Therefore, the 
biological efficacy of a soy protein-rich diet remains controversial. In addition, the final 
mechanism responsible for plasma cholesterol reduction remains to be elucidated, although 
nutrigenomic analysis has revealed significant differences in hepatic gene expression 
concerning lipid and energy metabolism, transcription factor regulation, and antioxidant 
enzyme production in animals fed soy protein compared with those fed casein (Nagasawa 
et al., 2002; Takamatsu et al., 2004).  
Several studies in cells and validated animal models have suggested that the mechanism of 
action of soy protein is related to the direct activation of low-density lipoprotein receptors or 
gene expression in liver cells (Khosla et al., 1989; Lovati et al., 2000; Manzoni et al., 2003), or 
modulation of both synthesis and catabolism of low-density lipoproteins by specific 
proportions of dietary amino acids corresponding to soy protein (Lovati et al., 1987; Sirtori 
et al., 1993; Tovar et al., 2002; Vahouny et al., 1996). Lovati et al. (1996, 2000) demonstrated 
that the smaller major peptide (i.e., 7S globulin) from soy protein, devoid of isoflavone 
components, inhibits apolipoprotein B secretion and sterol biosynthesis in HepG2 cells. 
Dietary soy protein hydrolysates not only inhibit the absorption of dietary lipids and 
increase the absorption of dietary carbohydrates but also augment postprandial energy 
expenditure, accompanied by a postprandial increase in the oxidation of dietary 
carbohydrates, in type II diabetic mice (Ishihara et al., 2003). 
2.2 Anti-obesity activity 
Recently, the incidence of obesity has dramatically increased. Obesity is considered a serious 
problem associated with the development of major human metabolic diseases. This 
phenomenon occurs as a result of an imbalance between energy intake and energy 
expenditure that leads to adipocyte accumulation (Aoyama et al., 2000a; Aoyama et al., 
2000b). Therefore, low-energy diets such as a high-protein diet, which helps maintain body 
protein during restricted energy intake, are used for treating obese patients with diabetes 
(Hwang et al., 2005). 
Obesity is caused by increased adipocyte hyperplasia and hypertrophy as well as fat 
storage, which induces the transformation of pre-adipocytes into adipocytes (Caro et al., 
1989). Nagasawa et al. (2003) reported that soy protein isolates can lower the triglyceride 
content and fatty acid synthase mRNA level in adipose tissue. Therefore, they suggested 
that soy protein isolates control the gene expressions in adipose tissue and effectively 
regulate adipogenesis. Further, the anti-obesity benefits of the black soybean peptide, such 
as reduction in body weight and adipose tissue weight, have been observed. 
Kim et al. (2007) synthesized a tripeptide from soy protein and investigated its activity. In 
Western blot analysis, the synthetic peptide exhibited a similar inhibitory effect to 5-
aminoimidazole-4-carboxamide riboside (AICAR), which inhibits the expressions of 
adipogenic markers and transcription factors for adipogenesis (Haro et al., 1996; Kim et al., 
2007).  
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2.3 Anti-inflammatory activity 
Peptide-induced anti-inflammatory activities include modulation of inflammation, binding 
of toxins, and neutralization of bacteria and fungi. Inflammation associated with skin 
conditions is often a result of bacterial involvement, partially because of lipopolysaccharide 
released from the outer membrane of Gram-negative bacteria and lipotechoic acid released 
from Gram-positive bacteria. Innate-immunity peptides such as defensins and LL-37 are 
known to bind and neutralize bacterial debris including lipopolysaccharide and lipotechoic 
acid, resulting in the downregulation of pro-inflammatory cytokines (Mookherjee et al., 
2006). Another example is the suppression of propionibacterium acne-stimulated cytokine 
release by granulysin-derived peptides (McInturff et al., 2005).  
Oligopeptide-10 (Granactive Oligopeptide-10; Grant Industries, Elmwood Park, NJ, USA), a 
synthetic peptide that binds to lipotechoic acid, has been developed for topical anti-acne 
treatment. It has also shown potential in mitigating symptoms associated with yeast and 
fungal colonization, such as in dandruff, seborrheic dermatitis, and tinea pedis (Howell, 
2007). The combination of oligopeptide-10 with a peptide capable of downregulating 
cytokine-mediated responses involving interleukin-6 and interleukin-8 may have multiple 
applications, particularly for sensitive skin. Such a product would combine the benefits of 
binding pro-inflammatory toxins and reducing redness. Recent findings also suggest that a 
lack of modulation of peptides of the innate system may contribute to various skin 
conditions (Schauber & Gallo, 2009). Notably, mounting evidence has shown that 
overexpression of a pro-inflammatory component of LL-37 is an important contributor to 
the development of rosacea (Yamasaki et al., 2007). 
2.4 Anticancer activity 
Soy protein may also have anticancer effects. Azuma et al. (2000) and Kanamoto et al. (2001) 
demonstrated that feeding of an insoluble, high-molecular-weight protein fraction prepared 
from a proteinase-treated soybean protein isolate suppressed colon and liver tumorigenesis 
induced by azoxymethane and dietary deoxycholate in experimental animals. Bile acid 
plays a critical role in liver and colon tumorigenesis. The authors hypothesized that the 
high-molecular-weight protein fraction exerted these protective effects against colon and 
liver tumorigenesis by interfering with the enterohepatic circulation of bile acids, thus 
inhibiting their resorption in the intestine and increasing their fecal excretion. Peptides 
found in the feces of animals fed with the high-molecular-weight protein fraction were rich 
in hydrophobic amino acids; therefore, the authors suggested that this protein fraction 
forms nondissociable complexes with bile acids in the intestine through hydrophobic 
binding, which are then excreted via feces. High-molecular-weight protein fractions may 
therefore be used in functional foods to prevent the tumor-promoting activity of bile acids in 
the liver and colon. 
2.5 Antioxidant activity 
A high level of reactive oxygen species causes DNA, protein, lipid, and carbohydrate 
damage in the host (Murosaki et al., 2000). Hydrolysates of soy proteins contain antioxidant 
peptides (Chen et al., 1998). These peptides show high activity against the peroxidation of 
linoleic acid, paraquat-induced oxidative stress in rats, and scavenging effects on 
peroxynitrite, active oxygen, and free radical species (Takenaka et al., 2003). They may 
therefore help prevent some free radical-related diseases. 
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2.6 Hypotensive activity 
The angiotensin-converting enzyme (dipeptidyl carboxypeptidase, EC 3.4.15.1) plays an 
important role in regulating blood pressure. It increases blood pressure by converting 
inactive angiotensin I to potent vasoconstrictor angiotensin II and inactivating the 
vasodilator bradykinin (Yang et al., 1970). Therefore, inhibition of the angiotensin-
converting enzyme reduces the activity of angiotensin II and increases the bradykinin level, 
thus lowering blood pressure.  
Soybean is a valuable source of inhibitors of the angiotensin-converting enzyme (Ahn et al., 
2000; Shin et al., 2001). Inhibitors of this enzyme are now widely used as antihypertensive 
agents, causing a fall in blood pressure comparable to that produced by thiazides, and 
calcium antagonists (Pool et al., 1989). Many peptides isolated by the hydrolysis of food 
proteins have inhibitory activity against the enzyme and reduce blood pressure after oral 
administration (Ahn et al., 2000; Je et al., 2004; Yamamoto, 1997). Daily use of food with such 
peptides may be effective in maintaining blood pressure at the normal level. 
2.7 Anti-fatigue activity 
Exercise-induced fatigue is a listlessness resulting from excessive exertion or “overexercise,” 
leading to diminished bodily and mental functions. It is attributable to the following factors. 
First, free radicals cause metabolic disturbances; both normal and exhaustive exercises can 
cause an increase in free radicals in hepatic tissues, resulting in hepatocyte damage (Gul et 
al., 2006; Voces et al., 1999). Second, exercise causes the production and accumulation of 
products of metabolism, such as lactic acid. Third, exercise promotes the mobilization and 
consumption of energy sources such as glycogen (Ikeuchi et al., 2006). In addition, 
overexercise diminishes the brain's supply of oxygen, which leads to fatigue. Soybean 
peptides purified by ultrafiltration and gel chromatography have been shown to extend the 
swimming time of mice, effectively delay increases in their blood lactate level, and enhance 
the storage of hepatic glycogen.  
Soybean peptides are rich in amino acids such as leucine (23.6%), valine (12.22%), lysine 
(10.01%), isoleucine (8.8%), and phenlyalanine (8.75%). In addition, soybean peptides 
contain 4.74% aspartate and 5.55% glutamate, which help in performing exercise 
(Guezennec et al., 1998) and delaying fatigue (Marquezi et al., 2003). A supply of amino 
acids, especially branched-chain amino acids, can improve exercise ability and markedly 
retard the catabolism of proteins in muscle during exercise (Blomstrand & Newsholme, 
1992). Bazzarva et al. (1992) indicated that the amount of amino acids, especially alanine, 
glycine, valine, gamma-aminobutyric acid, isoleucine, threonine, serine, and tyrosine, in the 
plasma decreases rapidly during endurance testing.  
Red mold rice contains alanine, valine, and serine, implying that consumption of this rice 
can enhance exercise ability via its constituent amino acids. In addition, red mold rice 
contains gamma-aminobutyric acid and glutamic acid, which have positive effects on the 
nervous system and could help in executing exercise (Guezennec et al., 1998). Marquezi et 
al. (2003) indicated that aspartic acid is helpful in oxidative deamination and can lower the 
blood ammonia concentration, thus delaying fatigue. 
2.8 Anti-aging activity 
Many protein hydrolysates have been used in cosmetic formulations for decades because of 
their ability to stimulate skin firmness, tone, and elasticity as well as counteract skin aging. 
Until now, these peptides were poorly studied and their efficacy was poorly demonstrated. 
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During aging, the epidermis and dermis become thin; therefore, an efficient anti-aging 
product should be able to stimulate the metabolism of senescent fibroblasts and 
keratinocytes in order to increase the quantity of extracellular matrix components such as 
collagen and glycosaminoglycans. A parallel study performed on an in vitro skin-equivalent 
model and with human volunteers demonstrated the efficacy of a specific soy biopeptide 
against aging. This biopeptide induced a significant increase in glycosaminoglycan synthesis 
both in vitro and in vivo after a one-month treatment. This new cosmetic ingredient was 
also able to stimulate collagen synthesis in vitro and in vivo (Andre-Frei et al., 1999). 
Enzyme-inhibitory peptides directly or indirectly inhibit the activity of enzymes. Protein or 
peptides naturally extracted from soybean seeds can inhibit the formation of proteinases 
(Centerchem, Inc., Norwalk, CT, USA). Soy protein is frequently used as an anti-aging, skin-
moisturizing, anti-solar, cleansing, and hair-promoting agent. In a randomized, double-
blind, placebo-controlled study (Sudel et al., 2005), soy extract and placebo creams were 
applied to the volar part of the forearm of 21 healthy women; the papillary index increased 
to a significantly greater extent with the soy extract cream than with the placebo cream (4.56 
vs. 3.76 arbitrary units, P < 0.05). Another study with a pseudorandomized design in 10 
Caucasian women indicated the superiority of 2% soy biopeptide emulsion to a placebo in 
terms of collagen synthesis and stimulation of glycosaminoglycan contents (Andre-Frei et 
al., 1999). 
3. Bioactive peptides produced by gene expression systems 
In the recent years, various small peptides isolated from proteolytic hydrolysates of food 
proteins have shown a variety of physiological activities (Fiat et al., 1993), such as 
modulating the autonomic nerve system, activating the cell immune mechanism, and 
improving cardiovascular system function. These discoveries are valuable for exploiting 
functional foods and developing new medicaments.  
The expression of heterologous proteins in microorganisms by genetic recombination is still 
the high point in the development and exploitation of modern biotechnology. An optimal 
expression system can be selected only if the productivity, bioactivity, purpose, and 
physicochemical characteristics of the protein of interest are taken into consideration, 
together with the cost, convenience, and safety of the system itself. E. coli has a typical 
prokaryotic expression system. Itakura et al. (1977) successfully expressed somatostatin, a 
mammalian peptide hormone, in E. coli, realizing the in vitro expression of a foreign gene in 
prokaryotic cells. The cost of the bioactive substance produced in medium was similar to 
that of the protein extracted from the brains of 500,000 sheep. The event is therefore 
regarded as a milestone in genetic engineering. To date, reformed E. coli has been used 
extensively as a cellular host for foreign protein expression because of its rapid growth, 
capacity for continuous fermentation, and relatively low cost. Many commercial expression 
systems designed for various applications and compatibilities are available. The T7-based 
pET expression system (Novagen, Merck KGaA, Darmstadt, Germany) is the most 
commonly used in recombinant protein preparation. In general, three forms of foreign 
proteins can be expressed in E. coli: fusion proteins, secreted proteins, and inclusion bodies. 
E. coli cannot perform the post-translational modifications (e.g., N- and O-linked 
glycosylation, fatty acid acylation, phosphorylation, and disulfide-bond formation) often 
required for proper folding of the secondary, tertiary, and quaternary structures as well as 
for the functional characteristics of the protein of interest. Obviously, these modifications 
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can affect the bioactivity, function, structure, solubility, stability, half-life, protease 
resistance, and compartmentalization of the protein (Jung & Williams, 1997). 
Figure 2 shows strategies to obtain bioactive peptides from soybean. To the best of our 
knowledge, the use of genetic engineering instead of other synthetic methods to obtain a 
protein or peptide is both time-saving and cost-effective. We have successfully used a 
commercial E. coli expression system to express recombinant lunasin (Liu & Pan, 2010). In 
the following section, we present a representative method to obtain recombinant lunasin by 
using an E. coli expression system. 
 
 
Fig. 2. Strategies for the purification and cloning of bioactive peptides from soybean. 
4. Recombinant lunasin 
4.1 Bioactive lunasin in current research 
Lunasin is a 43-amino acid peptide with nine aspartate residues (D) at the C-terminus, an 
Arg-Gly-Asp (RGD) cell adhesion motif, and a conserved region of chromatin-binding 
proteins (Odani et al., 1987a, 1987b). Previous studies showed that lunasin suppresses 
carcinogenesis triggered by chemical carcinogens and oncogenes both in vitro and in a 
mouse skin cancer model (Galvez et al., 2001). Hsieh et al. (2010) recently evaluated the 
anticancer properties of lunasin in breast cancer by using a xenograft mouse model. The US 
Food and Drug Administration recommends the consumption of 25 g of soy protein per day 
to lower cholesterol levels and reduce the risk of heart disease (Xiao, 2008); this supplies 
approximately 250 mg of lunasin. Whether this dose is sufficient for chemoprevention still 
needs to be determined. 
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In a human feeding trial for detecting the presence of lunasin in plasma after soy protein 
consumption, lunasin was found in the circulation, a key requirement for its bioactivity in 
the target organs (Dia et al., 2009). Recently, some studies showed that lunasin can reduce 
low-density lipoprotein and total cholesterol levels by directly inhibiting gene expression of 
3-hydroxy-3-methyl-glutaryl-CoA reductase, which reduces cholesterol biosynthesis, and 
increasing low-density lipoprotein receptor expression, which enhances clearance of plasma 
low-density lipoprotein cholesterol (Galvez, 2001). In 2001, Galvez applied the Pichia yeast 
expression system for large-scale production of lunasin. Besides, lunasin and lunasin-like 
peptides isolated from defatted soybean flour can inhibit inflammation in 
lipopolysaccharide-induced RAW 264.7 cells by suppressing the nuclear factor kappa B 
pathway (de Mejia & Dia, 2009). In addition, synthetic lunasin has antioxidant properties 
such as linoleic acid oxidation-inhibitory and 2,2'-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid) (ABTS) radical-scavenging activities (Hernández-Ledesma et al., 2009). 
Recently, lunasin from soybean was found to promote apoptosis of HT-29 colon cells by 
activating mitochondrial pathways and inducing nuclear clustering (Dia & de Mejia, 2010). 
4.2 Experimental design involving genetic synthesis 
Figure 3 shows the experimental design for obtaining recombinant lunasin. 
 
 
 
 
 
Fig. 3. Flow chart of a method for obtaining recombinant lunasin via E. coli (Liu & Pan, 
2010). 
In the experiment, the lunasin sequence from soybean was codon-optimized for high 
expression in E. coli by changing the original sequence of lunasin (Odani et al., 1987b) to 
highly frequent codons used in the host. As shown in Figure 4, synthesis of the lunasin gene 
was achieved by an overlapping extension polymerase chain reaction strategy using four 
oligonucleotides. 
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Fig. 4. Schematic of the overlapping extension polymerase chain reaction. Primer 2 and 3 
were used as template primers; primer 1 and 4 were used as forward and reverse primers. 
4.3 Purification and production 
Lunasin is a polypeptide derived from the small subunit of soybean cotyledon-specific 2S 
albumin. The current research is based on extraction by plant or chemical synthesis of this 
polypeptide (Galvez & de Lumen, 1999). The purification of lunasin from plant sources is 
tedious. To date, lunasin has been isolated from various plants such as soybean (Odani et 
al., 1987b), barley (Jeong et al., 2002), herbs (Solanum nigrum L.; Jeong et al., 2007a), wheat 
(Jeong et al., 2007b), and amaranth (Amaranthus hypochondriacus; Silva-Sanchez et al., 2008). 
Natural lunasin has been extracted and purified by ion exchange chromatography and 
immuno-affinity column chromatography. Commercial soy products contain reasonable 
amounts of lunasin, ranging from 5.48 mg of lunasin per gram of protein (defatted soy flour) 
to 16.52 mg of lunasin per gram of protein (soy concentrate) (Jeong et al., 2003). The lunasin 
content of extracts from different varieties of barley ranges from 5.93 to 8.71 mg of lunasin 
per gram of protein (Jeong et al., 2002) and 36.4 mg of lunasin per gram of protein in 
Solanum nigrum L extract (Jeong et al., 2007a). Wheat and amaranth extracts have 3.95–17.2 
mg lunasin per gram of protein (Jeong et al., 2007b) and 11.1 μg lunasin per gram of protein 
(Silva-Sanchez et al., 2008), respectively.  
Some heterologous eukaryotic proteins such as human insulin-like growth factor II, alpha-
interferon, and interleukin-2 have been expressed in E. coli (Dijkema et al., 1984). In our 
experiment, recombinant lunasin containing his-tag at the C-terminus was expressed in 
soluble form, which could be purified by immobilized metal affinity chromatography 
(Figure 5). After 4 h, the expression level was above 4.73 mg of recombinant his-tagged 
lunasin per liter of Luria–Bertani broth. This method does not affect the bacterial growth 
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and expression levels. Consequently, it is easier to use an E. coli genetic expression system to 
express a heterologous protein than to extract the protein from plants.  
 
 
Fig. 5. The flow chart of recombinant lunasin purified by IMAC. (Liu & Pan, 2010) 
4.4 Bioactivity 
For detecting the bioactivity of the recombinant peptide from E. coli, we used M10 and Raw 
264.7 cells to evaluate the levels of histone acetylation and anti-inflammation. We found that 
recombinant his-tagged lunasin expressed by E. coli decreases acetylation in M10 cells by 
approximately 26.6%. The results of a histone acetylation assay depend on the cell model 
and source of lunasin. Galvez et al. (2001) suggested that 2 μM of lunasin isolated from 
soybean can efficiently prevent histone acetylation in C3H and MCF-7 cells. Jeong et al. 
(2002) reported that N-butyrate-treated NIH3T3 cells show an approximately 18-fold 
decrease in H3 acetylation after treatment with lunasin extract from barley seeds. In MCF7 
cells, H3 acetylation can be completely inhibited by lunasin (Jeong et al., 2002). Recombinant 
his-tagged lunasin is a 92-amino acid peptide, almost double that of native lunasin (43-
amino acid residues) obtained from plants. The extra amino acid residues at the N- and C-
terminals do not appear to affect the bioactivity of the recombinant protein. 
Macrophage activation is associated with a significant proportion of lipopolysaccharide-
induced inflammation. During this process, active macrophages produce cytotoxic 
inflammatory mediators, including reactive oxygen and nitrogen intermediates, hydrolytic 
enzymes, lipid mediators, and inflammatory cytokines (Laskin & Pendino, 1995). In 
lipopolysaccharide-induced macrophages, nitric oxide is mainly produced via inducible 
nitric oxide synthetase (Knowles & Moncada, 1994), which is synthesized via the nuclear 
factor kappa B pathway, similar to tumor necrosis factor-alpha and other pro-inflammatory 
cytokines such as interleukin-1beta, interleukin-6, and interleukin-12. Dia et al. (2009) were 
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the first to indicate that lunasin isolated from defatted soybean flour has some anti-
inflammatory activity in RAW 264.7 cells; they found lunasin can inhibit the cyclooxygenase 
2–prostaglandin E2 and inducible nitric oxide synthetase–nitric oxide pathways. De Mejia 
and Dia et al (2009) reported that lunasin and lunasin-like peptides purified from defatted 
soybean flour inhibit inflammation in lipopolysaccharide-induced RAW 264.7 macrophages 
by suppressing the nuclear factor kappa B pathway. Chemically synthesized lunasin also 
has some antioxidant and anti-inflammatory properties (Hernández-Ledesma et al., 2009). 
Recombinant lunasin produced from E. coli can inhibit the release of pro-inflammatory 
cytokines (tumor necrosis factor-alpha and interleukin-1beta) and nitric oxide production. 
(Liu & Pan, 2010) 
5. Conclusion 
We have presented several opportunities for the industrial exploitation of soy-derived 
bioactive peptides to enhance health and prevent disease. In this chapter, we have 
introduced the physiological properties of bioactive peptides from soybean and provided an 
example on the expression of a recombinant peptide by genetic engineering. Choosing the 
right expression system requires adequate time and makes the difference between success 
and failure. Once the protein is expressed, a suitable purification scheme can be planned. As 
shown in Table 1, many bioactive peptides from soybean have been identified and can be 
applied in genetic expression systems to express important genes.  
 
Biological properties Peptides Reference  
Hypocholesterol peptides WGAPSL 
Ile-Ala-Glu-Lys 
Leu-Pro-Tyr-Pro 
Zhong et al., 2007 
Nagaoka et al., 2001 
Kwon et al., 2002 
Anticancer  X-Met-Leu-Pro-Ser-Tyr-Ser-
Pro-Tyr 
Kim et al., 2000 
ACE inhibitory peptides Asp-Leu-Pro Wu and Ding, 2001 
Hypotensive  Tyr-Val-Val-Phe-Lys 
Pro-Asn-Asn-Lys-Pro-Phe-
Gin 
Asn-Trp-Gly-Pro-Leu-Val 
Ile-Pro-Pro-Gly-Val-Pro-Tyr-
Trp-Thr 
Thr-Pro-Arg-Val-Phe 
RPLKPW 
Kodera and Nio, 2002 
 
 
 
 
 
 
Korhonen and Pihlanto, 2003 
Antihypertensive PGTAVFK Kitts and Weiler, 2003 
Immunostimulating 
peptide 
MITLAIPVNKPGR 
MITLAIPVN 
MITL 
Yoshikawa et al., 2000 
Antioxident peptide LLPHH Korhonen and Pihlanto, 2003 
Adipogenesis inhibitor Ile-Gln-Asn Kim et al., 2007 
Table 1. Some examples of bioactive peptides derived from soybean  
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